ZHX2 and B-cell chronic lymphocytic leukemia: Consistent with findings in HCC, low ZHX2 expression correlates with poor prognosis of thyroid cancer (7), multiple myeloma (8–10), and chronic lymphocytic leukemia (11, 12).